Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
about
PGRMC1 regulation by phosphorylation: potential new insights in controlling biological activity!The σ2 receptor: a novel protein for the imaging and treatment of cancer.Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.Plasma membrane proteomics and its application in clinical cancer biomarker discovery.S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumorsPathways driving the endocytosis of mutant and wild-type EGFR in cancer.Oocytes isolated from dairy cows with reduced ovarian reserve have a high frequency of aneuploidy and alterations in the localization of progesterone receptor membrane component 1 and aurora kinase B.Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cellsNeutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological AssessmentsProgesterone receptor membrane component 1 and its role in ovarian follicle growth.PGRMC1 participates in late events of bovine granulosa cells mitosis and oocyte meiosisMass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.Possible role of PGRMC1 in breast cancer development.Circulating tumour cells: insights into tumour heterogeneity.Proteomic analysis of tissue samples in translational breast cancer research.Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells.Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: comparison of four oestrogens.Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy.Hyaluronic acid-dependent protection against UVB-damaged human corneal cells.Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.New insight on a possible mechanism of progestogens in terms of breast cancer risk.Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.PGRMC1: a new biomarker for the estrogen receptor in breast cancer.Expression patterns of progesterone receptor membrane components 1 and 2 in endometria from women with and without endometriosis.Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.CYB5D2 enhances HeLa cells survival of etoposide-induced cytotoxicity.PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
P2860
Q26741983-7ECBDCA5-8349-4202-AB8F-7E3EA3F804FEQ33782364-2EA87DA6-7412-4406-8A6C-18FD1164E874Q33986752-903D80A3-5EC9-4E0A-BFE9-9A2618838FBBQ34042708-8E9449FE-BCE3-460F-A333-EFC47893F652Q34122107-76DAF6D4-E58C-4358-A570-D3C7C52EB1F2Q34250906-5A5D25B9-FBFD-450C-AD26-E399DF2AA42EQ34656815-56A26800-F442-43AA-9B63-47E535825DFEQ34781357-66B2BDBC-C66A-44E3-B370-7CF55186C5A4Q35617549-B9DAFE7D-2CD3-456C-9942-3CFCBDDD697DQ35667831-52853876-5BFC-4522-8741-7033E556D885Q35922605-A3093524-D502-4F8F-AA29-25CA008DE410Q36255955-0FC7E902-97C8-425C-A113-741067D00456Q36923989-9920D45B-19DE-4B13-AC45-DC85DBE3A23DQ37143188-13B49DA9-92F9-4708-A4C9-27949AEDE7B4Q37385278-65B64333-00EE-4648-A3FF-986B76EFEC02Q37721257-68B36B14-3F3E-4423-8FF4-2D7770B91494Q38024011-194D6943-3D69-4742-BD6E-15358B1B9954Q38113819-6C68E76D-D16C-477B-A7AE-B88065C9A31FQ38120824-B4180F07-C6AE-4002-9AA7-D30A24F9CFA6Q38212502-25F84858-B490-472A-9E3C-5857E5B93D92Q38326217-65FFEF35-9D61-4B78-B0B1-2E14A3C290CAQ38327714-F2F1B3E5-94CA-4233-ADC7-81736FA1DD44Q38957367-46F287FA-2157-4E3F-A937-DAFBEB126EAAQ39082987-34F196D1-508F-4B44-AE08-F8C67491BCC7Q39132756-3E7376A6-41BA-414A-AAEF-A7D379791C3EQ39473591-7BD43590-7086-4291-80DF-51CFBE547FA6Q39865023-F0AAC12C-DEE5-4CE8-AE22-C0BC63CBFDA7Q40953525-DAA7734F-2061-4683-8533-2FD0F99DC47EQ42700780-1890C64A-A723-4BA1-9167-380D7BD3453EQ43161284-310CE819-0D7D-4F0B-9CF0-476DF3DFB271Q44313450-9884E752-52CE-4032-A846-757CC513F3CCQ46602710-D8FBA3F5-2F93-4BE5-9B32-E3DDA0CA4EEAQ46865682-3977F754-0EBE-4BF5-AAD0-5E8AED551BF0Q53243201-E85ABDAB-50B9-453C-BD1C-A2A80C7A31F6Q53641821-4212CE80-E2CE-4659-ADAC-944B9B68A52AQ54251377-8335E089-3743-44CB-B598-0CF292EF4033
P2860
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@en
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@nl
type
label
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@en
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@nl
prefLabel
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@en
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@nl
P2093
P2860
P356
P1476
Breast cancer proteomics revea ...... ial phosphorylation of PGRMC1.
@en
P2093
Gerhard P Schwall
Hans Neubauer
Karl Sotlar
Michael A Cahill
Raffael Kurek
Slobodan Poznanovic
Susan E Clare
Ulrich Vogel
Werner Stegmann
Wojciech Wozny
P2860
P2888
P356
10.1186/BCR2155
P577
2008-10-15T00:00:00Z
P5875
P6179
1051998367